Transcripts

Allogene Therapeutics (ALLO) earnings call transcripts

Earnings call transcripts for Allogene Therapeutics, Inc., with a summary, the guidance given, and what analysts pressed on.

Open ALLO in Gloom →
Allogene Therapeutics' chart, financials and news, free in your browser.Open ALLO in Gloom →
  • Q2 2026 earnings call

    Management framed Alpha-3 as an access-led validation of allogeneic CAR-T, while keeping pivotal timing and enrollment targets unchanged.

    Aug 12, 2026Confident0.76